Hey MGP,
I share your frustration that more neurology and headache journals are not covering the obvious relationship between cluster headache and a vitamin D3 deficiency.
Moreover, if that relationship attracts interest, then the fact that taking 10,000 IU/day vitamin D3, Omega-3 fatty acids and the vitamin D3 co-factors to treat that deficiency is also a very effective cluster headache prophylactic, should deserve front page billing...
Making progress on such an article has been a slow uphill battle. I managed to get an abstract of results from the online survey of 110 CHers (190 as of 3 March 2016) taking this regimen to prevent their CH published in the American Academy of Neurology's journal
Neurology at the following link: Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

or
I was also invited to make a poster presentation at the 2014 AAN Annual Meeting in Philadelphia, PA in April of 2014. The poster presentation was well received and I've had a few neurologists start suggesting this regimen since then.
We face two major problems going forward with more articles like this. The first is obvious... no gold standard RCTs using vitamin D3 at a dose of 10,000 IU/day as the intervention for cluster headache. Even if such an RCT were possible, funding will be a problem and it's doubtful there would be sufficient participation to power such a study.
In addition, there is also a clear and present bias against treating a wide variety of medical conditions with vitamin D3 at therapeutic doses. Part of that bias is either built into the curriculum with disinformation about vitamin D3 or courses in vitamin D3 therapy are absent at nearly every contemporary medical school.
This bias is widespread frequently taking the form of fear mongering articles warning against the “dangers” of taking pharmacological doses of vitamin D3.
This bias also takes the form of opposition research as evidenced by the number of studies concluding U-shaped, J-shaped and reverse J-shaped mortality curves associated with increasing doses of vitamin D3 and resulting higher 25(OH)D serum concentrations.
An author of one of these opposition research studies had a clear conflict of interest being employed by several large Pharmaceutical firms.
This is all very disconcerting when you consider the fact that the FDA Adverse Event Reporting System (FAERS), has yet to report a single death attributed to vitamin D3.
In the mean time, providing outreach with information about the effectiveness of the anti-inflammatory regimen here at CH.com and Clusterbusters is paying off. It has attracted an estimated 500 CHers to this regimen since December of 2010. Many like you who are amazed at the simplicity and effectiveness of vitamin D3 as a CH preventative.
I'm also working on a paper titled:
Why Most Clinical Trials Listing Vitamin D3 (Cholecalciferol) as the Intervention, Fail to Conclude Improved Clinical Outcomes Favoring the Benefits of Vitamin D3. It's based in part on a survey of RCTs and CTs registered in clinicaltrials.gov.
The good news is there have been 760 RCTs, CTs and OS listing vitamin D3, (Cholecalciferol), as the intervention registered in clinicaltrials.gov between 01/01/2000 and 12/07/2015. 730 of these studies have been registered since January of 2005. 380 of the 760 studies are listed as completed and 60 are listed as having results.
The following chart provides a early look at some of the results.
Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

or

The other good news as the above chart illustrates, is the vitamin D3 genie is out of the bottle...
I hope to have this paper published later this summer.
Take care and hang in there. It's posts like yours that help attract more CHers to this regimen.
V/R, Batch